Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Olema Pharmaceuticals, Inc. (OLMA) had Pre-Tax Income of $-63.20M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-63.20M |
|
-- |
|
-- |
|
$67.18M |
|
$-67.18M |
|
$3.98M |
|
|
Pre-Tax Income |
$-63.20M |
$-63.20M |
|
$-63.20M |
|
$-63.20M |
|
$-63.20M |
|
$-63.20M |
|
$-67.18M |
|
$-67.08M |
|
104.45M |
|
104.45M |
|
$-0.61 |
|
$-0.61 |
|
| Balance Sheet Financials | |
$469.88M |
|
-- |
|
$16.70M |
|
$486.58M |
|
$53.01M |
|
$3.00M |
|
$3.00M |
|
$56.01M |
|
$430.56M |
|
$430.56M |
|
$430.56M |
|
87.45M |
|
| Cash Flow Statement Financials | |
$-91.88M |
|
$45.37M |
|
$46.81M |
|
$48.30M |
|
$48.60M |
|
$0.30M |
|
$23.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.86 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-92.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.68% |
|
-14.68% |
|
-12.99% |
|
-14.58% |
|
$4.92 |
|
$-0.88 |
|
$-0.88 |
|